NASDAQ: CGEM · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Cullinan Therapeutics Inc.

How Cullinan Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$994.3M

Price

$15.45

P/E

-4.9

EPS (TTM)

$-3.18

1-year return

100.9%

Dividend yield

0.0%

52-week range

$8.72–$15.63

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources